Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record, including its study design, eligibility criteria, locations, outcomes, and supporting documents, rather than a 403 error message.
    Difference
    100%
    Check dated 2026-11-12T12:40:07.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-29T13:51:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T14:12:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-15T13:54:29.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T14:20:58.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The EV-302 study record page now renders a 403 Forbidden error, replacing the usual study content with a minimal error screen. The page shows a Home button instead of the detailed study information.
    Difference
    17%
    Check dated 2026-09-24T18:33:46.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.